Walgreen said its fiscal second-quarter earnings eased as the drug-store operator was hit by weaker margins tied to a slowdown in generic drug introductions and a milder flu season.
via WSJ.com: US Business http://ift.tt/1jBX1pA
via WSJ.com: US Business http://ift.tt/1jBX1pA
Nessun commento:
Posta un commento